abstract |
use of 17 beta- (3-furyl) -5 betaandrostane- 3 beta, 14 beta, 17 alpha-triol in the preparation of a medicament for the prevention or treatment of diseases due to liver fibrosis the present invention relates to one of the formula (i), in which the symbol has the meaning reported in the text; for the preparation of a medicine for the prevention and / or treatment of obstructive vascular lesions after vascular surgery and for the prevention and / or treatment of diseases due to organ fibrosis. |